These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7119572)

  • 1. Metabolic heterogeneity of low density lipoprotein-apoB production in familial hypercholesterolemia: an analytical model solution of tracer data.
    Eaton RP; Allen RC; Schade DS
    J Lipid Res; 1982 Jul; 23(5):738-46. PubMed ID: 7119572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.
    Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U
    J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic pathways of apolipoprotein B in heterozygous familial hypercholesterolemia: studies with a [3H]leucine tracer.
    Fisher WR; Zech LA; Kilgore LL; Stacpoole PW
    J Lipid Res; 1991 Nov; 32(11):1823-36. PubMed ID: 1770302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approach.
    Pietzsch J; Wiedemann B; Julius U; Nitzsche S; Gehrisch S; Bergmann S; Leonhardt W; Jaross W; Hanefeld M
    J Lipid Res; 1996 Oct; 37(10):2074-87. PubMed ID: 8906585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of very low density and intermediate density lipoproteins in patients with familial hypercholesterolaemia.
    Soutar AK; Myant NB; Thompson GR
    Atherosclerosis; 1982 Jun; 43(2-3):217-31. PubMed ID: 7115461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of weekly LDL-apheresis on metabolic parameters of apolipoprotein B in heterozygous familial hypercholesterolemia.
    Parhofer KG; Barrett PH; Demant T; Richter WO; Schwandt P
    J Lipid Res; 1996 Nov; 37(11):2383-93. PubMed ID: 8978490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins.
    Gaw A; Packard CJ; Lindsay GM; Griffin BA; Caslake MJ; Lorimer AR; Shepherd J
    J Lipid Res; 1995 Jan; 36(1):158-71. PubMed ID: 7706941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologic mechanisms of action of lovastatin in nephrotic syndrome.
    Aguilar-Salinas CA; Barrett PH; Kelber J; Delmez J; Schonfeld G
    J Lipid Res; 1995 Jan; 36(1):188-99. PubMed ID: 7706943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional regulation of cholesterol synthesis and apolipoprotein B kinetics: studies in patients with familial hypercholesterolemia and normal subjects treated with a high carbohydrate, low fat diet.
    Stacpoole PW; von Bergmann K; Kilgore LL; Zech LA; Fisher WR
    J Lipid Res; 1991 Nov; 32(11):1837-48. PubMed ID: 1770303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
    Ryomoto KI; Suzuki M; Kanazawa A; Hasegawa M; Kimura Y; Yamamura T; Harano Y
    Am J Hypertens; 2000 Jun; 13(6 Pt 1):617-24. PubMed ID: 10912744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm.
    Fisher WR; Zech LA; Stacpoole PW
    Arterioscler Thromb; 1994 Apr; 14(4):501-10. PubMed ID: 8148348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions.
    Packard CJ; Demant T; Stewart JP; Bedford D; Caslake MJ; Schwertfeger G; Bedynek A; Shepherd J; Seidel D
    J Lipid Res; 2000 Feb; 41(2):305-18. PubMed ID: 10681415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.
    Arad Y; Ramakrishnan R; Ginsberg HN
    J Lipid Res; 1990 Apr; 31(4):567-82. PubMed ID: 2351867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.
    Teng B; Sniderman AD; Soutar AK; Thompson GR
    J Clin Invest; 1986 Mar; 77(3):663-72. PubMed ID: 3949973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia.
    Maugeais C; Ouguerram K; Frénais R; Maugère P; Charbonnel B; Magot T; Krempf M
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1679-86. PubMed ID: 11297603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overproduction of a kinetic subclass of VLDL-apoB, and direct catabolism of VLDL-apoB in human endogenous hypertriglyceridemia: an analytical model solution of tracer data.
    Eaton RP; Allen RC; Schade DS
    J Lipid Res; 1983 Oct; 24(10):1291-303. PubMed ID: 6644179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia.
    Demant T; Gaw A; Watts GF; Durrington P; Buckley B; Imrie CW; Wilson C; Packard CJ; Shepherd J
    J Lipid Res; 1993 Jan; 34(1):147-56. PubMed ID: 8445339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism.
    Packard CJ; Gaw A; Demant T; Shepherd J
    J Lipid Res; 1995 Jan; 36(1):172-87. PubMed ID: 7706942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperbetalipoproteinemia with small low-density lipoprotein, a characteristic disorder of lipoprotein in essential hypertension.
    Ikeda K; Suzuki M; Ikebuchi M; Hara Y; Tsushima M; Yamamoto A; Harano Y
    J Diabetes Complications; 1995; 9(4):227-9. PubMed ID: 8573733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.